Kobayashi Pharmaceutical Co., Ltd.
KBYPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $437,716 | $590,948 | $558,923 | $716,615 |
| - Cash | $50,873 | $71,536 | $96,233 | $95,024 |
| + Debt | $846 | $987 | $792 | $630 |
| Enterprise Value | $387,689 | $520,399 | $463,482 | $622,221 |
| Revenue | $165,600 | $173,455 | $166,258 | $155,252 |
| % Growth | -4.5% | 4.3% | 7.1% | – |
| Gross Profit | $87,603 | $96,376 | $92,331 | $88,774 |
| % Margin | 52.9% | 55.6% | 55.5% | 57.2% |
| EBITDA | $21,964 | $33,645 | $31,864 | $30,786 |
| % Margin | 13.3% | 19.4% | 19.2% | 19.8% |
| Net Income | $10,067 | $20,338 | $20,022 | $19,715 |
| % Margin | 6.1% | 11.7% | 12% | 12.7% |
| EPS Diluted | 135.42 | 268.16 | 259.59 | 252.36 |
| % Growth | -49.5% | 3.3% | 2.9% | – |
| Operating Cash Flow | $11,246 | $18,360 | $31,914 | $22,419 |
| Capital Expenditures | -$26,629 | -$13,569 | -$16,229 | -$4,185 |
| Free Cash Flow | -$15,383 | $4,791 | $15,685 | $18,234 |